|
RLIM expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.71249999994616E-06 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.92889999999624E-05 |
| Normal-vs-Stage2 |
2.598000E-03 |
| Normal-vs-Stage3 |
1.65693999999439E-05 |
| Normal-vs-Stage4 |
1.87058999999712E-05 |
| Stage1-vs-Stage2 |
8.865400E-01 |
| Stage1-vs-Stage3 |
3.260800E-01 |
| Stage1-vs-Stage4 |
1.303000E-01 |
| Stage2-vs-Stage3 |
5.959400E-01 |
| Stage2-vs-Stage4 |
3.632000E-01 |
| Stage3-vs-Stage4 |
5.883600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.53590999999453E-05 |
| Normal-vs-AfricanAmerican |
3.059000E-01 |
| Normal-vs-Asian |
1.033860E-04 |
| Caucasian-vs-AfricanAmerican |
6.019900E-02 |
| Caucasian-vs-Asian |
5.069200E-01 |
| AfricanAmerican-vs-Asian |
3.575800E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.10619999999606E-05 |
| Normal-vs-Female |
1.84795000000015E-05 |
| Male-vs-Female |
6.602400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.354500E-04 |
| Normal-vs-Age(41-60Yrs) |
1.5661499999986E-05 |
| Normal-vs-Age(61-80Yrs) |
2.08329999999979E-05 |
| Normal-vs-Age(81-100Yrs) |
1.048590E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.477400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.905250E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.198200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.263000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.874600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.878400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.786560E-01 |
| Classical-VS-Follicular |
4.878800E-03 |
| Classical-VS-Other |
1.994960E-01 |
| Classical-VS-Normal |
4.556100E-04 |
| Tall-VS-Follicular |
6.455400E-01 |
| Tall-VS-Other |
5.059600E-01 |
| Tall-VS-Normal |
7.376100E-04 |
| Follicular-VS-Other |
7.389200E-01 |
| Follicular-VS-Normal |
1.41570000000701E-06 |
| Other-VS-Normal |
1.547800E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.07149999994949E-06 |
| Normal-vs-N1 |
4.08130000000284E-05 |
| N0-vs-N1 |
4.530800E-01 |
|
|
